Home›Search›European Pharmaceutical Law Review

European Pharmaceutical Law Review

Lexxion Verlagsgesellschaft mbH · Germany · Est. 2017

ISSN2511-7157

SJR Q4✓ Scopus / SJR

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Bottom 25%

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.109

H-Indexi

Total Worksi

147

Total Citationsi

160

2yr Mean Citednessi

0.00

Open Impact Factor alternative

Aims & Scope

Subject areas: Drug Discovery; Law; Pharmaceutical Science; Pharmacology, Toxicology and Pharmaceutics (miscellaneous).

General Information

Country / RegionGermany

Primary Language—

1st Year Published2017

Annual Volume~ 34 articles / year

StatusActive (last: 2021)

Total Publications147

Visit Journal Website

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

5/11 · 45%

✅

Do you know the journal / publisher?

Lexxion Verlagsgesellschaft mbH

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2511-7157

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2017

2018

2019

2020

2021

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Drug DiscoveryQ4

LawQ4

Pharmaceutical ScienceQ4

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q4

Subject Classification

Scopus Categories

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)LawDrug DiscoveryPharmaceutical Science

Research Topics (OpenAlex)

Pharmaceutical Economics and PolicyHealth Systems, Economic Evaluations, Quality of LifeInternational Arbitration and Investment LawScience, Research, and MedicineConflict of Laws and JurisdictionIntellectual Property and PatentsInternational Law and AviationBiomedical Ethics and RegulationEuropean and International Law StudiesLaw, AI, and Intellectual Property

Frequently asked questions about European Pharmaceutical Law Review

Is European Pharmaceutical Law Review a predatory journal?

PubScope has no integrity flags on record for European Pharmaceutical Law Review: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of European Pharmaceutical Law Review?

European Pharmaceutical Law Review is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.109.

Is European Pharmaceutical Law Review indexed in Scopus and Web of Science?

European Pharmaceutical Law Review is indexed in Scopus.

What is the aims and scope of European Pharmaceutical Law Review?